Yellow fever vaccine Foundation to improve the vaccine from the "Asibi" strain, discovered that a favorable chance mutation in the attenuated virus had produced a highly efficacious strain that was named 17D. After field trials in Brazil, over one million people were vaccinated by 1939, without severe complications. For his work on the yellow fever vaccine, Theiler received the 1951 Nobel Prize in Physiology or Medicine. Only the 17D vaccine remains in use today. The outbreak of yellow fever in Angola in January 2016 has raised concerns about whether the global supply of vaccine is adequate to meet the need during a large
Nobel Prize effect winners estimated that winning the Nobel Prize correlated with one or two years of additional longevity for the recipient, compared to being merely nominated for the prize. Nobel Prize effect The Nobel Prize effect is an observation about the adverse effects of winning the Nobel Prize on laureates and their careers. These effects include reduced productivity, constraints in areas of work, and public perception of expertise in areas unrelated to the laureate's work. The term Nobel effect is also used in those contexts, as well as in the context of the winner's longevity, and influence on international law in the